发明名称 Modalities for the treatment of degenerative diseases of the retina
摘要 This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment epithelium (RPE) cells and other retinal progenitor cells.
申请公布号 US9080150(B2) 申请公布日期 2015.07.14
申请号 US201213477763 申请日期 2012.05.22
申请人 Ocata Therapeutics, Inc. 发明人 Klimanskaya Irina V.;Lanza Robert
分类号 A61K35/12;C12N5/0793;A61K35/44;A61K49/00;A61P27/02;C12N5/071;C12N5/079;A61K35/30;A61K35/36;A61K35/545 主分类号 A61K35/12
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method of producing a human RPE cell preparation suitable for transplantation into the eye of a human patient in need thereof, comprising: (a) differentiating in vitro human pluripotent cells that express Oct-4, alkaline phosphatase, SSEA-3, SSEA-4, TRA-I-60, and TRA-I-81 under conditions that do not maintain the undifferentiated state of the human pluripotent cells to obtain a heterogeneous population of human cells including pigmented cells comprising brown pigment dispersed in their cytoplasm; (b) culturing the pigmented cells to form a monolayer of RPE cells having a cobblestone, polygonal, epithelial-like appearance that express RPE65 and bestrophin, and (c) isolating and purifying said RPE cells.
地址 Marlborough MA US